Drug Manufacturers - Specialty & Generic | Healthcare
Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Market Cap
1227796905984
Current Price
1520.1
52 Week Range
1335.0 - 1702.05
Previous Close
1510.8
Open
1512.5
Sector
Healthcare
Address
Cipla House, Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, 400013, India
Phone
+91-22248-26000
Fax
+91-22248-26120
Website
https://www.cipla.com
Day Low
1509.4
Day High
1523.8
Dividend Yield
0.86
PE Ratio
23.236013
Earnings Per Share
65.42
Beta
0.158
EBITDA
71279001600
Book Value
386.241
EPS
61.83079
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Umang Vohra B.E., M.B.A. | MD, Global CEO & Executive Director | 53 | 1971 |
Dr. Raju Sunil Mistry M.A., Ph.D. | President & Global Chief People Officer | 59 | 1965 |
Mr. Pradeep Bhadauria | President & Global Chief Scientific Officer | - | - |
Mr. Ashish Adukia | Global Chief Financial Officer | - | - |
Mr. Achin Gupta | Global Chief Operating Officer | 48 | 1976 |
Mr. Dinesh Ramniranjan Jain | Senior VP & Head of Corporate Finance | - | - |
Ms. Sneha Hiranandani B Com | Chief Information Officer | - | - |
Ms. Diksha Maheshwari | Head of Investor Relations | - | - |
Mr. Rajendra Kumar Chopra | Compliance Officer & Company Secretary | - | - |
Ms. Heena Kanal | Senior Vice-President of Corporate Communications | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.